Neuer Name...
kam gerade eine Email...COOL kann sich nicht erklären, warum der Kurs so plötzlich gefallen ist. Man glaubt, das waren "verächtliche" Leerverkäufe...
https://www.stockwatch.com/News/Item/...0901-U!CLABF-20210506/U/CLABF
Akome Biotech Ltd. (“Akome”) has commenced the development of its next-generation patent pending psychedelic drug formulation for the treatment of Alzheimer’s Disease (“Alzheimer’s”).
Akome Biotech Ltd. (“Akome”) has commenced the development of its next-generation patent pending psychedelic drug formulation for the treatment of Alzheimer’s Disease (“Alzheimer’s”).